Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1755 ARTÍCULOS , VIENDO DEL 16 AL 30

The Outcomes of Small-Molecule Kinase Inhibitors and the Role of ROCK2 as a Molecular Target for the Treatment of Alzheimer's Disease

Tolomeu HV, Fraga CAM.

CNS Neurol Disord Drug Targets. 2022;21(2):188-205. doi: 10.2174/1871527320666210820092220.

PLGA-Based Curcumin Delivery System: An Interesting Therapeutic Approach in the Treatment of Alzheimer's Disease

Shahbaz SK, Koushki K, Sathyapalan T, Majeed M, Sahebkar A.

Curr Neuropharmacol. 2022;20(2):309-323. doi: 10.2174/1570159X19666210823103020.

Interleukin-17A in Alzheimer's Disease: Recent Advances and Controversies

Yan XZ, Lai L, Ao Q, Tian XH, Zhang YH.

Curr Neuropharmacol. 2022;20(2):372-383. doi: 10.2174/1570159X19666210823110004.

Immunotherapeutics for AD: A Work in Progress

Sharma A, Anand JS, Kumar Y.

CNS Neurol Disord Drug Targets. 2022;21(9):752-765. doi: 10.2174/1871527320666210903101522.

Targeted Delivery of Montelukast for the Treatment of Alzheimer's Disease

Datusalia AK, Singh G, Yadav N, Gaun S, Manik M, Singh RK.

CNS Neurol Disord Drug Targets. 2022;21(10):913-925. doi: 10.2174/1871527320666210902163756.

Alzheimer's Disease and other Tauopathies: Exploring Efficacy of Medicinal Plant-derived Compounds in Alleviating Tau-mediated Neurodegeneration

Durairajan SSK, Selvarasu K, Bera MR, Rajaram K, Iyaswamy A, Li M.

Curr Mol Pharmacol. 2022;15(2):361-379. doi: 10.2174/1874467214666210906125318.

ODor-evoked Autobiographical Memory in Alzheimer's disease?

El Haj M.

Arch Clin Neuropsychol. 2022 Feb 23;37(2):513-520. doi: 10.1093/arclin/acab074.

Nanotherapeutics for Alzheimer's Disease with Preclinical Evaluation and Clinical Trials: Challenges, Promises and Limitations

Bukhari SNA.

Curr Drug Deliv. 2022;19(1):17-31. doi: 10.2174/1567201818666210910162750.

Neuroinflammatory Signaling in the Pathogenesis of Alzheimer's Disease

Uddin MS, Kabir MT, Jalouli M, Rahman MA, Jeandet P, Behl T, Alexiou A, Albadrani GM, Abdel-Daim MM, Perveen A, Ashraf GM.

Curr Neuropharmacol. 2022;20(1):126-146. doi: 10.2174/1570159X19666210826130210.

Research Progress in Predicting DNA Methylation Modifications and the Relation with Human Diseases

Ao C, Gao L, Yu L.

Curr Med Chem. 2022;29(5):822-836. doi: 10.2174/0929867328666210917115733.

Phytotherapeutics against Alzheimer's Disease: Mechanism, Molecular Targets and Challenges for Drug Development

Gayathri S, Raghu CH, Fayaz SM.

CNS Neurol Disord Drug Targets. 2022;21(5):409-426. doi: 10.2174/1871527320666210920120612.

Acetylcholinesterase Enzyme Inhibitor Molecules with Therapeutic Potential for Alzheimer's Disease

Sivaraman B, Raji V, Velmurugan BA, Natarajan R.

CNS Neurol Disord Drug Targets. 2022;21(5):427-449. doi: 10.2174/1871527320666210928160159.

Ketogenic Diet: A Promising Neuroprotective Composition for Managing Alzheimer's Diseases and its Pathological Mechanisms

Sridharan B, Lee MJ.

Curr Mol Med. 2022;22(7):640-656. doi: 10.2174/1566524021666211004104703.

Precision Psychiatry: Machine Learning as a Tool to Find New Pharmacological Targets

Rema J, Novais F, Telles-Correia D.

Curr Top Med Chem. 2022;22(15):1261-1269. doi: 10.2174/1568026621666211004095917.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias